MindWave Innovations Launches NILA Token on Licensed U.S. Exchange, Paving Way for MindChain

MindWave Innovations Inc. (NYSE American: APUS), a wholly owned subsidiary of Apimeds Pharmaceuticals US Inc., has announced that its NILA token is now available to eligible U.S. users on Webot, a licensed U.S. cryptocurrency exchange. This marks the first time the token can be accessed through a regulated U.S. platform, a significant milestone for the company as it prepares for the planned October 2026 launch of MindChain, its insured Layer 2 blockchain.

The listing on Webot is a strategic move that increases NILA's accessibility and liquidity for U.S. investors, subject to regulatory compliance. According to the company, the token is expected to migrate to MindChain's native network upon launch, where it will be used for transaction fees, staking, and network security. However, this migration is contingent upon the completion of legal, regulatory, technical, and compliance requirements.

This development underscores MindWave's commitment to building enterprise blockchain infrastructure that meets regulatory standards. By offering NILA on a licensed U.S. exchange, the company aims to bridge the gap between traditional finance and the emerging digital asset space, particularly in regulated financial services and real-world asset tokenization.

The launch comes at a time when institutional interest in blockchain technology is growing, but regulatory clarity remains a key hurdle. MindWave's approach, which includes insurance for its Layer 2 network, could set a precedent for other projects seeking to operate within the U.S. regulatory framework.

For more information on MindWave Innovations and its projects, visit the company's newsroom at https://cnw.fm/APUS.

The full press release is available at https://ccw.fm/WEHk1.